144 related articles for article (PubMed ID: 10063572)
1. [Results of the European multicenter study of radionuclide mammography with Tc-99m-MIBI].
Grünwald F; Palmedo H; Mallmann P; Biersack HJ
Zentralbl Chir; 1998; 123 Suppl 5():47-8. PubMed ID: 10063572
[TBL] [Abstract][Full Text] [Related]
2. (99M)Technetium-sestamibi scintimammography in non-palpable breast lesions found on screening X-ray mammography.
Gommans GM; van der Zant FM; van Dongen A; Boer RO; Teule GJ; de Waard JW
Eur J Surg Oncol; 2007 Feb; 33(1):23-7. PubMed ID: 17126524
[TBL] [Abstract][Full Text] [Related]
3. [A Spanish multicenter scintigraphic study of the breast using Tc 99m MIBI. Report of results].
Prats E; Carril J; Herranz R; Meroño E; Banzo J; Gtemegmmt YE
Rev Esp Med Nucl; 1998; 17(5):338-50. PubMed ID: 9812008
[TBL] [Abstract][Full Text] [Related]
4. Imaging in situ breast carcinoma (with or without an invasive component) with technetium-99m pentavalent dimercaptosuccinic acid and technetium-99m 2-methoxy isobutyl isonitrile scintimammography.
Papantoniou V; Tsiouris S; Mainta E; Valotassiou V; Souvatzoglou M; Sotiropoulou M; Nakopoulou L; Lazaris D; Louvrou A; Melissinou M; Tzannetaki A; Pirmettis I; Koutsikos J; Zerva C
Breast Cancer Res; 2005; 7(1):R33-45. PubMed ID: 15642168
[TBL] [Abstract][Full Text] [Related]
5. Technetium-99m sestamibi scintimammography complements mammography in the detection of breast cancer.
Krishnaiah G; Sher-Ahmed A; Ugwu-Dike M; Regan P; Singer J; Totoonchie A; Spiegler E; Sardi A
Breast J; 2003; 9(4):288-94. PubMed ID: 12846862
[TBL] [Abstract][Full Text] [Related]
6. Technetium-99m-MIBI scintimammography in palpable and nonpalpable breast lesions.
Mekhmandarov S; Sandbank J; Cohen M; Lelcuk S; Lubin E
J Nucl Med; 1998 Jan; 39(1):86-91. PubMed ID: 9443742
[TBL] [Abstract][Full Text] [Related]
7. Carcinoembryonic antigen immunoscintigraphy complements mammography in the diagnosis of breast carcinoma.
Goldenberg DM; Abdel-Nabi H; Sullivan CL; Serafini A; Seldin D; Barron B; Lamki L; Line B; Wegener WA
Cancer; 2000 Jul; 89(1):104-15. PubMed ID: 10897007
[TBL] [Abstract][Full Text] [Related]
8. Uptake and washout of 99mTcV-dimercaptosuccinic acid and 99mTc-sestamibi in the assessment of histological type and grade in breast cancer.
Papantoniou V; Christodoulidou J; Papadaki E; Valotassiou V; Souvatzoglou M; Louvrou A; Feida H; Sotiropoulou M; Pampouras G; Michalas S; Zerva C
Nucl Med Commun; 2002 May; 23(5):461-7. PubMed ID: 11973487
[TBL] [Abstract][Full Text] [Related]
9. Scintimammography with technetium-99m tetrofosmin in suspected breast cancer.
Schillaci O; Scopinaro F; Danieli R; Picardi V; Tavolaro R; Cannas P; Colella AC
Anticancer Res; 1997; 17(3B):1623-6. PubMed ID: 9179206
[TBL] [Abstract][Full Text] [Related]
10. Detection of bilateral multifocal breast cancer using Tc-99m sestamibi imaging. The role of delayed imaging.
Derebek E; Balci P; Alanyali H; Kocdor MA; Capa G; Gorken IB; Degirmenci B; Alakavuklar M; Canda T; Durak H
Clin Nucl Med; 1999 Aug; 24(8):590-3. PubMed ID: 10439180
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity and specificity of planar scintimammography with 99mTc-sestamibi.
Danielsson R; Boné B; Gad A; Sylvan M; Aspelin P
Acta Radiol; 1999 Jul; 40(4):394-9. PubMed ID: 10394867
[TBL] [Abstract][Full Text] [Related]
12. Technetium-99m sestamibi scintimammography: the influence of histopathological characteristics, lesion size and the presence of carcinoma in situ in the detection of breast carcinoma.
Howarth D; Sillar R; Clark D; Lan L
Eur J Nucl Med; 1999 Nov; 26(11):1475-81. PubMed ID: 10552090
[TBL] [Abstract][Full Text] [Related]
13. [Differentiation of benign and malignant palpable breast masses using 99mTc-MIBI imaging].
He J; Li Y; Su J
Hunan Yi Ke Da Xue Xue Bao; 1997; 22(3):226-8. PubMed ID: 9868120
[TBL] [Abstract][Full Text] [Related]
14. Value of 99m-Tc MIBI and 99m-Tc(V) DMSA scintigraphy in evaluation of breast mass lesions.
Ambrus E; Rajtár M; Ormándi K; Séra T; Tószegi A; Láng J; Pávics L; Csernay L
Anticancer Res; 1997; 17(3B):1599-605. PubMed ID: 9179201
[TBL] [Abstract][Full Text] [Related]
15. Scintimammography with Tc-99m sestamibi.
Khalkhali I; Iraniha S; Cutrone JA; Diggles LE; Klein SR
Acta Med Austriaca; 1997; 24(2):46-9. PubMed ID: 9227786
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of technetium-99m tetrofosmin mammoscintigraphy as compared to mammography for detecting and differentiating palpable breast masses of young Taiwanese women.
Hoi YJ; Hsieh JF; Tsai SC; Sun SS; Kao CH
Anticancer Res; 2000; 20(3B):2061-4. PubMed ID: 10928152
[TBL] [Abstract][Full Text] [Related]
17. Scintimammography with technetium-99m methoxyisobutylisonitrile: results of a prospective European multicentre trial.
Palmedo H; Biersack HJ; Lastoria S; Maublant J; Prats E; Stegner HE; Bourgeois P; Hustinx R; Hilson AJ; Bischof-Delaloye A
Eur J Nucl Med; 1998 Apr; 25(4):375-85. PubMed ID: 9553167
[TBL] [Abstract][Full Text] [Related]
18. 99mTc sestamibi scintimammography. Screening mammographic non-palpable suspicious breast lesions: preliminary results.
Bekiş R; Derebek E; Balci P; Koçdor MA; Değirmenci B; Canda T; Durak H
Nuklearmedizin; 2004 Feb; 43(1):16-20. PubMed ID: 14978536
[TBL] [Abstract][Full Text] [Related]
19. Role of MIBI breast scintigraphy in evaluation of palpable breast lesions.
Lam WW; Yang WT; Chan YL; Stewart IE; King W; Metreweli C
Br J Radiol; 1996 Dec; 69(828):1152-8. PubMed ID: 9135472
[TBL] [Abstract][Full Text] [Related]
20. 99mTc-MIBI prone scintimammography in patients with high and intermediate risk mammography.
Scopinaro F; Ierardi M; Porfiri LM; Tiberio NS; De Vincentis G; Mezi S; Cannas P; Gigliotti T; Marzetti L
Anticancer Res; 1997; 17(3B):1635-8. PubMed ID: 9179209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
